(NewsUSA) - More than 100,000 Americans have said goodbye to their common skin cancer without requiring surgery, owing to a relatively new noninvasive treatment available at many dermatology practices around the nation.

Arizona resident Patty Focken was deeply anxious in 2021 when she learned that a sore on her nose was nonmelanoma skin cancer, a type that’s more common in the U.S. than all other cancers combined. “I was concerned,” she says, “with the possibility of surgical scarring that might accompany a Mohs procedure.” Instead, she found a local dermatologist who offered the GentleCure™ nonsurgical treatment option.

Her doctor used low-level x-rays, like those used in dental offices, guided with hi-definition ultrasound imaging, to kill the cancer cells over a series of 15-minute sessions. The cure rate (freedom from recurrence at six years) for this GentleCure treatment, technically known as Image-Guided SRT, has been shown to be greater than 99 percent, similar to Mohs surgery, with no pain, surgical scarring or downtime.

Focken has enjoyed a lifetime of outdoor activities, dating back to childhood days spent in a backyard pool and on the family boat, often with minimal sun protection. Cumulative sun exposure is the primary cause of skin cancer, although other factors, such as light skin, use of tanning beds or a weakened immune system can increase one’s cancer risk.

Upon moving to Phoenix in 2021, Focken immediately sought out a dermatology practice offering GentleCure as an option, as she was aware that she was at higher risk for a second cancer diagnosis.

Last December, her dermatologist detected a new cancerous lesion on Focken’s forehead and determined that GentleCure was an appropriate treatment option. In a matter of weeks, that cancer was successfully treated and Focken had become the 100,000^th patient to experience the GentleCure solution. “The sessions lasted only minutes,” Focken notes, “and there was nothing to indicate to others that I was in treatment.”

Today, Focken spends countless hours with her grandchildren at the Phoenix Zoo and enjoying other outdoor activities, but always with high-SPF sunscreen and protective clothing. “If any of my friends or family ever get skin cancer in the future,” she says, “there is no question that I will encourage them to discuss the GentleCure option with a dermatologist.”

Kerwin Brandt, CEO of SkinCure Oncology, the company that supports GentleCure in dermatology practices, notes, “In a very short time, GentleCure has won widespread adoption among dermatologists, with more than half of those who offer it being Mohs surgeons who are eager to provide their appropriate patients with a noninvasive option for common skin cancers. Patient satisfaction runs above 99 percent, reflecting the value of this treatment and the quality of service provided by the physicians and radiation therapists who administer it.”

More information about the GentleCure Experience is available at GentleCure.com.